Drug Shortage Report for SANDOZ SITAGLIPTIN-METFORMIN
| Report ID | 198833 |
| Drug Identification Number | 02503964 |
| Brand name | SANDOZ SITAGLIPTIN-METFORMIN |
| Common or Proper name | SITAGLIPTIN-METFORMIN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
| Strength(s) | 850MG 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 60FCT BO |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2023-07-17 |
| Estimated end date | 2023-08-04 |
| Actual end date | 2023-08-07 |
| Shortage status | Resolved |
| Updated date | 2023-08-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-08-08 | English | Compare |
| v5 | 2023-08-07 | French | Compare |
| v4 | 2023-08-07 | English | Compare |
| v3 | 2023-07-18 | English | Compare |
| v2 | 2023-07-17 | French | Compare |
| v1 | 2023-07-17 | English | Compare |
Showing 1 to 6 of 6